Cover Image
市場調查報告書

中國的血液檢驗市場:血型判斷、免疫測量、核酸增幅檢查 (NAT)

Blood Testing Market in China (Typing, Immunoassay, NAT Testing)

出版商 Kalorama Information 商品編碼 357127
出版日期 內容資訊 英文 50 Pages
訂單完成後即時交付
價格
Back to Top
中國的血液檢驗市場:血型判斷、免疫測量、核酸增幅檢查 (NAT) Blood Testing Market in China (Typing, Immunoassay, NAT Testing)
出版日期: 2016年04月20日 內容資訊: 英文 50 Pages
簡介

本報告提供中國的血液檢驗市場調查,中國的市場背景、醫療環境,對國際企業來說的法律規章、政策上的課題,血液供給量、血液中心數等資料,血液銀行所使用的各種檢驗概要,各種檢驗的市場規模的成果、預測,主要經營者簡介等彙整資料。

第1章 摘要整理

  • 概要
  • 中國的醫療、血液銀行環境
  • 調查範圍、調查手法
  • 中國的血液檢驗市場
  • 主要調查結果

第2章 簡介

  • 人口趨勢、疾病人口
  • 國際企業的法律規章、政策上的課題

第3章 中國的血液檢驗市場環境

  • 血液銀行所使用的檢驗
  • 核酸增幅檢查 (NAT)
  • 免疫測量
  • 血型判斷
  • 特定地區的捐血、相關設施資料

第4章 市場分析

  • 市場概要

第5章 企業簡介

  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • DiaSorin
  • Grifols
  • Immucor
  • Ortho Clinical Diagnostics
  • PerkinElmer
  • Roche
  • China Health Labs & Diagnostics, Ltd.
  • Daan Gene Co., Ltd.

圖表

目錄
Product Code: KLI5975604

Blood Testing Market in China (Typing, Immunoassay, NAT Testing) offers the most current look at the blood testing IVD market in China, including tests for blood typing, immunoassay-based tests and NAT Tests. The data gathered are the result of interviews conducted with experts and blood banking professionals in China. This report provides market sizing and forecasts for the major types of blood bank tests in the Chinese market. It also provides province-level statistics on the number of blood centers and the types of blood centers.

Blood Testing Market in China provides market analysis and data on the blood testing market environment in China, including:

  • Blood Center Stations in China by Type (Provincial, Regional, County, Cord, Plasma, Other)
  • China Blood Supply Statistics
  • Blood Supply Centers in Beijing
  • Blood Supply in China (tons)
  • Blood Supply in China (tons) by Type (Voluntary Unpaid Blood Donation/Paid Plasma Donation)
  • Blood Testing Market in China (Typing, Immunoassay, NAT), 2015 and 2020
  • Progress of Conversion (Provincial, Regional, County, Plasma Collection) Percentage Using NAT Testing

There are some 497 blood collection centers in China. The types of blood centers differ from provincial level, county level and regional medical centers. The report provides province-level statistics on the number of blood centers and the types of blood centers, including the number of blood supply stations and stations for collection of plasma. Data are provided for the following provinces:

  • Beijing
  • Guangdong
  • Henan
  • Shaanxi
  • Guangxi
  • Heilongjiang
  • Yunnan

Blood Testing Market in China offers an assessment of the current blood supply in the country, making conclusions regarding China's demand for blood, progress in the collection and testing of blood, and the capacity for NAT testing and opportunities for makers of NAT equipment. The report also estimates the market for blood testing and typing equipment in China in 2015 and 2020.

The report profiles companies in the market and speculates on the best opportunities for test makers. Companies profiled include:

  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • DiaSorin
  • Grifols
  • Immucor
  • Ortho Clinical Diagnostics
  • PerkinElmer
  • Roche
  • China Health Labs & Diagnostics, Ltd.
  • Daan Gene Co., Ltd.

U.S. dollar figures represent the Chinese market and are expressed in current dollars. Sales estimates are provided for 2015 and forecasts are provided through 2020. Information for this report was gathered using both primary and secondary research sources. Kalorama Information, working with The Freedonia Group's office in Beijing, conducted primary research rounds including interviews with national experts and managers at blood collection centers across China. Certain provincial blood centers were a focus of the study to offer a mix of rural and urban provinces, including Shaanxi, Guangdong, Beijing, Henan, Yunnan, and Heilongjiang. The report also benefited from a wide variety of published sources including company reports, catalogs, materials and public filings; government documents; trade journals; newspapers and business press; analysts' reports and other sources.

Table of Contents

CHAPTER ONE: EXECUTIVE SUMMARY

  • Overview
  • Chinese Healthcare and Blood Banking Environment
  • Scope and Methodology
  • Blood Testing Market in China
  • Major Findings of the Report

CHAPTER TWO: INTRODUCTION

  • Population Trends and Disease Demographics
  • Regulation and Policy Challenges for International Companies

CHAPTER THREE: BLOOD TESTING MARKET ENVIRONMENT IN CHINA

  • Tests Used in Blood Banking
  • Nucleic-Acid Testing (NAT)
  • Immunoassays
  • Typing
  • Blood Donation and Facilities Data for Specific Provinces

CHAPTER FOUR: MARKET ANALYSIS

  • Market Overview

CHAPTER FIVE: COMPANY PROFILES

  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • DiaSorin
  • Grifols
  • Immucor
  • Ortho Clinical Diagnostics
  • PerkinElmer
  • Roche
  • China Health Labs & Diagnostics, Ltd.
  • Daan Gene Co., Ltd.
  • LIST OF FIGURES

CHAPTER ONE: EXECUTIVE SUMMARY

  • Figure 1-1: Blood Testing Market in China, 2015 and 2020
  • Figure 1-2: China's Blood Supply, 2010-2015
  • Figure 1-3: Blood Centers in China, Selected Provinces (Beijing, Guangdong, Henan, Shaanxi,Guangxi, Heilongjiang, Yunnan)

CHAPTER TWO: INTRODUCTION

  • Figure 2-1: Total IVD Market in China, 2015 and 2020
  • Figure 2-2: Hospitals in China, 2004-2015

CHAPTER THREE: BLOOD TESTING MARKET ENVIRONMENT IN CHINA

  • Figure 3-1: Blood Center Stations in China by Type (Provincial, Regional, County,Cord, Plasma, Other)
  • Figure 3-2: China Blood Supply Statistics
  • Table 3-1: Blood Supply Centers in Beijing
  • Table 3-2: Blood Centers in Guangdong
  • Table 3-3: Blood Centers in Henan
  • Table 3-4: Blood Centers in Shaanxi
  • Table 3-5: Blood Centers in Guangxi
  • Table 3-6: Blood Centers in Heilongjiang
  • Table 3-7: Blood Centers in Yunnan
  • Figure 3-3: Blood Supply in China (tons)
  • Figure 3-4: Blood Supply in China (tons) by Type (Voluntary Unpaid Blood Donation/Paid Plasma Donation)

CHAPTER FOUR: MARKET ANALYSIS

  • Figure 4-1: Blood Testing Market in China (Typing, Immunoassay, NAT), 2015 and 2020
  • Figure 4-2: Progress of Conversion (Provincial, Regional, County, Plasma Collection)Percentage Using NAT Testing
Back to Top